Comparing anti-tau antibodies under clinical trials and their epitopes on tau pathologies
Saved in:
| Main Authors: | Ha-Lim Song, Min-Seok Kim, Woo-Young Cho, Ye-Seul Yoo, Jae-You Kim, Tae-Wook Kim, Hyori Kim, Dong-Hou Kim, Seung-Yong Yoon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Series: | Molecular Neurodegeneration |
| Online Access: | https://doi.org/10.1186/s13024-024-00769-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease
by: Abdolhossein Zare, et al.
Published: (2025-07-01) -
PERK activation mitigates tau pathology in vitro and in vivo
by: Julius Bruch, et al.
Published: (2017-02-01) -
Detecting amyloid and tau pathology in Parkinson’s disease, 4R-tauopathies and control subjects with plasma pTau217
by: Giulia Musso, et al.
Published: (2025-08-01) -
Immunoelectron microscopy and biochemical studies using three anti-tau antibodies in human brains: associations between pTau and ribosomes
by: Douglas Price, et al.
Published: (2025-07-01) -
Nec‐1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice
by: Seung‐Hoon Yang, et al.
Published: (2016-11-01)